Final results of a prospective, observational study of the effectiveness of darbepoetin alfa administered every three weeks for the treatment of chemotherapy-induced anaemia in elderly patients

被引：0
|
作者：
Esquerdo, G.
Domenech, M.
Bermejo, J. C.
Lopez, P.
Pedro, C.
Villadiego, K.
Constenla, M.
Sanchez-Rovira, P.
Gasquet, J. A.
Rodriguez, C. A.
机构：
[1] Clin Benidorm, Barcelona, Spain
[2] Althaia, Barcelona, Spain
[3] H Sagrat Cor, Barcelona, Spain
[4] H Virgen Nieves, Granada, Spain
[5] H del Mar, Barcelona, Spain
[6] H Pontevedra, Pontevedra, Spain
[7] H Jaen, Jaen, Spain
[8] Amgen SA, Barcelona, Spain
[9] H Univ Salamanca, Salamanca, Spain
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2009年 / 27卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e20654
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Effectiveness of darbepoetin alfa administered every three weeks to elderly patients with chemotherapy-induced anemia
    Gasent, J. M.
    Bermejo, J. C., II
    Lopez, P.
    Domenech, M.
    Sanchez-Rovira, P.
    Villadiego, K.
    de Pedro, C.
    Iturralde, P.
    Gasquet, J. A.
    Rodriguez, C. A.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [2] Darbepoetin alfa administered every three weeks is effective for the treatment of chemotherapy-induced anemia
    Boccia, Ralph
    Malik, Imtiaz A.
    Raja, Vinay
    Kahanic, Stephen
    Liu, Randall
    Lillie, Tom
    Tomita, Dianne
    Clowney, Billy
    Silberstein, Peter
    ONCOLOGIST, 2006, 11 (04): : 409 - 417
  • [3] A prospective observational study of the effectiveness, safety, and effect on fatigue of darbepoetin alfa for the treatment of chemotherapy-induced anaemia
    Mel, J. R.
    Salar, A.
    Rodriguez, C. A.
    Alegre, A.
    Gonzalez, A.
    Cassinello, J.
    Montesinos, J.
    Gasquet, J. A.
    Sanchez, J.
    Saigi, E.
    CURRENT MEDICAL RESEARCH AND OPINION, 2008, 24 (10) : 2931 - 2942
  • [4] Darbepoetin alfa administered once every three weeks is effective for treating chemotherapy-induced anemia.
    Canon, JL
    Bodoky, G
    Mateos, MV
    Bastit, L
    Ferreira, I
    Amado, R
    Vansteenkiste, J
    BREAST CANCER RESEARCH AND TREATMENT, 2005, 94 : S216 - S216
  • [5] Darbepoetin alfa in the treatment of chemotherapy-induced anaemia
    Wauters, Isabelle
    Vansteenkiste, Johan
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2009, 9 (02) : 221 - 230
  • [6] Observational AranespA® Survey to Investigate the Q3W Schedule (OASIS): a prospective observational study of treatment of chemotherapy-induced anaemia with every 3 weeks darbepoetin alfa
    Pat, K.
    Anrys, B.
    Verhulst, D.
    Van Aelst, F.
    Van Eygen, K.
    Galdermans, D.
    Verhoeven, D.
    Polus, M.
    Segers, K.
    Derde, M. P.
    Wauters, I.
    Vansteenkiste, J.
    SUPPORTIVE CARE IN CANCER, 2009, 17 (02) : 211 - 215
  • [7] Observational Aranesp® Survey to Investigate the Q3W Schedule (OASIS): a prospective observational study of treatment of chemotherapy-induced anaemia with every 3 weeks darbepoetin alfa
    K. Pat
    B. Anrys
    D. Verhulst
    F. Van Aelst
    K. Van Eygen
    D. Galdermans
    D. Verhoeven
    M. Polus
    K. Segers
    M. P. Derde
    I. Wauters
    J. Vansteenkiste
    Supportive Care in Cancer, 2009, 17 : 211 - 215
  • [8] DARBEPOETIN ALFA DOSING WEEKLY AND EVERY THREE WEEKS IN CANCER PATIENTS WITH CHEMOTHERAPY-INDUCED ANAEMIA - EFFICACY DATA FROM THE CHOICE STUDY
    Van Belle, S.
    Urbanski, K.
    Orfeuvre, H.
    Foucher, P.
    Wheeler, T.
    Pujol, B.
    ANNALS OF ONCOLOGY, 2010, 21 : 386 - 386
  • [9] Effectiveness of darbepoetin alfa administered every 3 weeks on clinical outcomes in patients with hematologic malignancies and chemotherapy-induced anemia.
    Boccia, RV
    Silberstein, PT
    Tchekmedyian, S
    Tomita, D
    Rossi, G
    Otterson, G
    BLOOD, 2005, 106 (11) : 20B - 20B
  • [10] The effectiveness of darbepoetin alfa administered every 3 weeks on hematologic outcomes and quality of life in older patients with chemotherapy-induced anemia
    Boccia, Ralph
    Lillie, Tom
    Tomita, Dianne
    Balducci, Lodovico
    ONCOLOGIST, 2007, 12 (05): : 584 - 593
12345